878 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Not yet recruiting Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer
Condition: Bronchial Cancer
Intervention: Device: With and without SDB
3 Recruiting Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients
Conditions: Carcinoma, Non-Small-Cell Lung;   Bronchial Neoplasms;   Carcinoma, Bronchogenic;   Lung Diseases;   Lung Neoplasms
Intervention:
4 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
5 Not yet recruiting International Lung Screen Trial (ILST)
Conditions: Non-small Cell Lung Cancer;   Lung Neoplasms;   Respiratory Tract Neoplasms;   Thoracic Neoplasms;   Neoplasms by Site;   Neoplasms;   Lung Diseases;   Respiratory Tract Diseases;   Smokers at Risk of Lung Cancer
Intervention: Radiation: Low dose CT
6 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
7 Recruiting Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage IB and II Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Durvalumab;   Other: Durvalumab plus SBRT
8 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
9 Not yet recruiting Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Durvalumab
10 Recruiting Oncolytic Adenovirus-Mediated Gene Therapy for Lung Cancer
Condition: Non-small Cell Lung Cancer Stage I
Intervention: Biological: Ad5-yCD/mutTKSR39rep-ADP Adenovirus
11 Recruiting NY-ESO-1 TCR (TAEST16001)for Patients With Advanced NSCLC
Condition: Lung Cancer, Nonsmall Cell, Recurrent
Interventions: Drug: Cyclophosphamide;   Biological: Anti-NY-ESO-1 TCR transduced T cells
12 Not yet recruiting Nivolumab in Treating Patients With Stage IV or Recurrent Lung Cancer With High Mutation Loads
Conditions: Recurrent Non-Small Cell Lung Carcinoma;   Stage IV Non-Small Cell Lung Cancer
Interventions: Biological: Nivolumab;   Other: Laboratory Biomarker Analysis
13 Recruiting A Study of Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Atezolizumab;   Drug: Daratumumab
14 Not yet recruiting Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy
Condition: Non-small Cell Lung Cancer
Intervention:
15 Not yet recruiting Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)
Condition: Advanced Non-small Cell Lung Cancer
Intervention: Drug: Atezolizumab
16 Not yet recruiting Evaluation of a Food Intake Modification for Lung Cancer Patients
Conditions: Carcinoma, Non-Small-Cell Lung;   Antineoplastic Agents
Interventions: Other: Food Intake Modification;   Other: Habitual Food Intake
17 Recruiting High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer Metastatic
Intervention: Biological: high-activity natural killer
18 Recruiting Study of Consolidation Chemotherapy For Locoregional Recurrence Of Non-small Cell Lung Cancer After Surgical Resection
Condition: Non-small Cell Lung Cancer
Interventions: Drug: consolidation chemotherapy of pemetrexed/docetaxel;   Radiation: split-course chest radiation;   Drug: concurrent chemotherapy
19 Not yet recruiting MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)
Conditions: Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma;   Advanced Lung Cancer;   Recurrent Nonsmall Cell Lung Cancer
Interventions: Drug: Selumetinib;   Drug: Durvalumab;   Behavioral: Phone Calls
20 Not yet recruiting A Study of Durvalumab Versus Standard of Care in Advanced Non Small-Cell Lung Cancer
Condition: Non Small Cell Lung Carcinoma (NSCLC)
Interventions: Biological: Durvalumab (MEDI4736);   Drug: Paclitaxel + carboplatin;   Drug: Gemcitabine + cisplatin;   Drug: Gemcitabine + carboplatin;   Drug: Pemetrexed + cisplatin;   Drug: Pemetrexed + carboplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.